Skip to content
Preclinical Data Forum

Coming Soon: Call for submissions for the
2022 Best Negative Data Prize

Who We Are

The Global Preclinical Data Forum is a jointly sponsored U.S. and European initiative that encourages global collaboration to address the challenge of ensuring that preclinical research is reproducible, robust and translatable to support disease research utility for clinical research & development (R&D).
United States Sponsor:
Cohen Veterans Bioscience
European Sponsor:
European College of Neuropsychopharmacology

Members

News

Negative Data Prize

Our Work

News & Events

Training Workshop: “How to Make Preclinical Research Robust”
In January 2021, several members of the Global Preclinical Data Forum (GPDF) held a series of training seminars in conjunction with members of EQIPD (European Quality in Preclinical Data) project, called "How to Make Preclinical Research Robust". This training series was part of a new collaboration between EQIPD and the IMI-PainCare consortium.
Global Preclinical Data Forum and European College of Neuropsychopharmacology Announce the Winner of the 2020 Best Negative Data Prize
The Global Preclinical Data Forum (GPDF), a jointly sponsored U.S. and European initiative, funded by Cohen Veterans Bioscience (CVB) and the European College of Neuropsychopharmacology (ECNP), announced today the winner of the 2020 "Best Negative Data Prize." The prize is awarded to the researcher or research group whose neuroscience study best exemplifies data where the outcomes do not confirm the expected results or working hypothesis. The goal of the unusual award is to incentivize researchers to publish negative findings to demonstrate that all data holds value for the scientific process.